Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02880384 · ClinicalTrials.gov registry record · NA
Pathogen Detection and Community Acquired Pneumonia
A NA study, sponsored by Providence Health & Services.
- Completed
- Registry status
- NA
- Development phase
- 570
- Enrollment target
NCT02880384 is a NA study that has completed, run by Providence Health & Services. The registered enrollment target is 570 participants.
The verdict
NCT02880384, a NA study, has completed, sponsored by Providence Health & Services.
- COMPLETED
- Registry status
- NA
- Development phase
- 570 participants
- Enrollment target
Study Summary
Study to compare the number of community-acquired pneumonia (CAP) pathogens detected using current diagnostic tests to the number detected using the BioFire Diagnostics investigational polymerase chain reaction (PCR) platform.
Interventions
- OTHER FilmArray LRTI v.2.0 IUO Panel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 570 participants |
| Start Date | 2017-01 |
| Est. Completion | 2020-12-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02880384
The ClinicalTrials.gov registry entry for NCT02880384 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 570 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Providence Health & Services, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FilmArray LRTI v.2.0 IUO Panel is the first listed.
NCT02880384 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02880384 about?
NCT02880384 is a clinical study titled "Pathogen Detection and Community Acquired Pneumonia". Study to compare the number of community-acquired pneumonia (CAP) pathogens detected using current diagnostic tests to the number detected using the BioFire Diagnostics investigational polymerase chain reaction (PCR) platform.
What is the current status of trial NCT02880384?
This trial is currently completed. It is a NA study. The enrollment target is 570 participants. The study started on 2017-01. Estimated completion is 2020-12-20.
What interventions are being tested in trial NCT02880384?
The interventions under investigation include: FilmArray LRTI v.2.0 IUO Panel (OTHER).
Who is sponsoring clinical trial NCT02880384?
This trial is sponsored by Providence Health & Services, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.